# Trails Edge Capital Partners, LP: Form 13F holdings

An institutional investment manager in ATLANTA, GA. SEC CIK 2077247.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $629.9m
- Positions: 35 (35 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/2077247/000207724726000004/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [LB PHARMACEUTICALS INC (LBRX)](/companies/lbrx.md) | COM SHS | $49.4m | 7.8% | 1,523,022 |  | Added +203,660 |
| [NURIX THERAPEUTICS INC (NRIX)](/companies/nrix.md) | COM | $38.2m | 6.1% | 1,573,220 |  | Reduced −170,000 |
| [IMMUNOCORE HLDGS PLC (IMCR)](/companies/imcr.md) | ADS | $33.8m | 5.4% | 1,063,234 |  | Added +380,637 |
| [FIRST TRACKS BIOTHERAPEUTICS (TRAX)](/companies/trax.md) | ORD SHS | $30.5m | 4.8% | 1,514,000 |  | New +1,514,000 |
| [4D MOLECULAR THERAPEUTICS IN (FDMT)](/companies/fdmt.md) | COM | $29.6m | 4.7% | 2,227,917 |  | Added +925,000 |
| [BIOMARIN PHARMACEUTICAL INC (BMRN)](/companies/bmrn.md) | COM | $29.3m | 4.7% | 512,000 |  | New +512,000 |
| [DESIGN THERAPEUTICS INC (DSGN)](/companies/dsgn.md) | COM | $29.0m | 4.6% | 2,001,282 |  | Added +1,149,269 |
| [XENON PHARMACEUTICALS INC (XENE)](/companies/xene.md) | COM | $26.6m | 4.2% | 440,000 |  | Unchanged |
| [MIRUM PHARMACEUTICALS INC (MIRM)](/companies/mirm.md) | COM | $26.1m | 4.2% | 223,312 |  | Reduced −110,000 |
| [INSMED INC (INSM)](/companies/insm.md) | COM PAR $.01 | $24.6m | 3.9% | 230,331 |  | New +230,331 |
| [CYTOKINETICS INC (CYTK)](/companies/cytk.md) | COM NEW | $24.5m | 3.9% | 288,089 |  | Reduced −11,911 |
| [SYNDAX PHARMACEUTICALS INC (SNDX)](/companies/sndx.md) | COM | $24.3m | 3.9% | 1,110,000 |  | Added +408,179 |
| [NEUROGENE INC (NGNE)](/companies/ngne.md) | COM | $22.5m | 3.6% | 714,885 |  | Reduced −67,902 |
| [KAILERA THERAPEUTICS INC (KLRA)](/companies/klra.md) | COMMON STOCK | $21.7m | 3.4% | 984,786 |  | New +984,786 |
| [REVOLUTION MEDICINES INC (RVMD)](/companies/rvmd.md) | COM | $21.7m | 3.4% | 115,750 |  | Reduced −129,250 |
| [INHIBIKASE THERAPEUTICS INC (IKT)](/companies/ikt.md) | COM NEW | $18.4m | 2.9% | 9,051,318 |  | Added +993,973 |
| [INCYTE CORP (INCY)](/companies/incy.md) | COM | $17.6m | 2.8% | 155,000 |  | New +155,000 |
| [AVALO THERAPEUTICS INC (AVTX)](/companies/avtx.md) | COM NEW | $16.5m | 2.6% | 891,881 |  | New +891,881 |
| [MOONLAKE IMMUNOTHERAPEUTICS (MLTX)](/companies/mltx.md) | CLASS A ORD | $14.6m | 2.3% | 750,000 |  | New +750,000 |
| [FAETH THERAPEUTICS INC (FTH)](/companies/fth.md) | COM NEW | $12.9m | 2.0% | 515,335 |  | Added +390,335 |
| [X4 PHARMACEUTICALS INC (XFOR)](/companies/xfor.md) | COM NEW | $12.0m | 1.9% | 2,571,478 |  | Unchanged |
| [OPUS GENETICS INC (IRD)](/companies/ird.md) | COM | $11.3m | 1.8% | 2,743,658 |  | Added +2,243,658 |
| SOL-GEL TECHNOLOGIES LTD | SHS NEW | $10.3m | 1.6% | 139,445 |  | Added +53,949 |
| [AURA BIOSCIENCES INC (AURA)](/companies/aura.md) | COM | $10.2m | 1.6% | 1,443,333 |  | New +1,443,333 |
| [CENTURY THERAPEUTICS INC (IPSC)](/companies/ipsc.md) | COM | $10.1m | 1.6% | 4,134,969 |  | Added +1,684,976 |
| [INVENTIVA SA (IVA)](/companies/iva.md) | ADS | $10.0m | 1.6% | 2,657,997 |  | Unchanged |
| [CAMP4 THERAPEUTICS CORP (CAMP)](/companies/camp.md) | COM | $8.4m | 1.3% | 1,932,937 |  | Reduced −6,626 |
| [ALTIMMUNE INC (ALT)](/companies/alt.md) | COM NEW | $8.1m | 1.3% | 2,660,000 |  | New +2,660,000 |
| [MINERVA NEUROSCIENCES INC (NERV)](/companies/nerv.md) | COM NEW | $7.9m | 1.3% | 1,419,000 |  | Unchanged |
| [PROMIS NEUROSCIENCES INC (PMN)](/companies/pmn.md) | COM SHS | $7.3m | 1.2% | 557,103 |  | Unchanged |
| [ONKURE THERAPEUTICS INC (OKUR)](/companies/okur.md) | COM CL A | $6.6m | 1.0% | 1,438,456 |  | New +1,438,456 |
| FORTE BIOSCIENCES INC | COM NEW | $5.8m | 0.9% | 273,181 |  | New +273,181 |
| RESEARCH ALLIANCE CORP III | ORD SHS CL A | $5.3m | 0.8% | 500,000 |  | New +500,000 |
| [VTV THERAPEUTICS INC (VTVT)](/companies/vtvt.md) | CL A NEW | $3.2m | 0.5% | 85,192 |  | Reduced −54,386 |
| [IMAGENEBIO INC (IMA)](/companies/ima.md) | COM | $1.7m | 0.3% | 282,004 |  | New +282,004 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ARCUS BIOSCIENCES INC (RCUS)](/companies/rcus.md) | COM | $0 | 0.0% | 0 |  | Sold out −1,047,935 |
| [DEFINIUM THERAPEUTICS INC (DFTX)](/companies/dftx.md) | COM SHS | $0 | 0.0% | 0 |  | Sold out −1,738,110 |
| [IMMUNOVANT INC (IMVT)](/companies/imvt.md) | COM | $0 | 0.0% | 0 |  | Sold out −414,054 |
| [VAXCYTE INC (PCVX)](/companies/pcvx.md) | COM | $0 | 0.0% | 0 |  | Sold out −662,470 |
| [XENON PHARMACEUTICALS INC (XENE)](/companies/xene.md) | COM | $0 | 0.0% | 0 | Put | Sold out −200,000 |

Source: SEC EDGAR, Form 13F-HR, accession 0002077247-26-000004. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.